GOLDSTEIN JOSEPH L received a stock award from REGENERON PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/6/2026ACC: 0001225474-26-000002
Director
Since Jul 2018
+2.12K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
2.12K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+155.00
Price / share
—
Trade value
—
% of position
2.4%
1/2/2026
6.55K→6.70K
Total
Net shares
+155.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2026 | A · Award | +155.00 | — | — | 2.4% | 6.55K | 6.70K |
| Total | +155.00 | $0.00 | ||||||
Derivative Transactions1
Non-Qualified Stock Option (right to buy)
Direct
Converts to
Common Stock
1.96K shares
Shares
+1.96K
Strike price
772.76
Held after
1.96K
Exercisable
—
1/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock1.96K shares | 1/2/2026 | A · Award | +1.96K | 772.76 | — | 1.96K |